Barron's Weekend Stock Picks: Uber Joins The S&P 500, Schwab Rebounds And What's Next for Johnson & Johnson?
Barron's Weekend Stock Picks: Uber Joins The S&P 500, Schwab Rebounds And What's Next for Johnson & Johnson?
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
In "Uber Joins the S&P 500. Here's Which Other Stocks Did—and Which Ones Were Removed," Andrew Bary writes that Uber Technologies Inc's (NYSE:UBER) addition to the S&P 500 comes after the company's recent profitability and makes it the largest inclusion of a U.S. company by market capitalization that was not previously in the index.
本辛加回顾了本周末巴伦周末报道的热门报道。以下是投资者需要阅读的文章。
在 “优步加入标准普尔500指数” 中。以下是其他哪些股票确实如此,哪些股票被移除。” 安德鲁·巴里写道,Uber Technologies Inc(纽约证券交易所代码:UBER)加入标准普尔500指数是在该公司最近实现盈利之后出现的,按市值计算,这是该指数中前所未有的最大一家。
In "Phillips 66 Stock Could Rise More on Activist Investor's Prodding," Carleton English writes that Elliott Management's $1 billion stake in multinational energy company Phillips 66 (NYSE:PSX) seeks changes for a potential 75% stock increase, challenging CEO Mark Lashier's plans as Wall Street supports the activist's push.
卡尔顿·英吉利斯在《激进投资者的推动下,菲利普斯66股票可能进一步上涨》中写道,埃利奥特管理公司持有的跨国能源公司菲利普斯66(纽约证券交易所代码:PSX)的10亿美元股份寻求变动,以实现股价可能上涨75%,这挑战了首席执行官马克·拉希尔的计划,因为华尔街支持该激进分子的推动。
In "Schwab's Stock Rebounds. Why It Could Gain More Next Year," Andrew Welsch writes that Charles Schwab's (NYSE:SCHW) stock rose around 12% this past week despite challenges, driven by optimistic outlooks by analysts.
在 “施瓦布的股票反弹” 中。为什么明年能涨幅更大。” 安德鲁·韦尔施写道,在分析师乐观前景的推动下,尽管面临挑战,但查尔斯·施瓦布(纽约证券交易所代码:SCHW)的股票在过去一周仍上涨了约12%。
In "Apple Stock Has Tough Decembers. Why This Time Could Be Different," Angela Palumbo writes that, while December historically shows weak performance for Apple Inc (NASDAQ:AAPL) stock, this year brings hope with high holiday expectations and improved supply conditions from the previous year.
在 “苹果股票十二月表现艰难” 中。为什么这次可能会有所不同。” 安吉拉·帕伦博写道,尽管12月份苹果公司(纳斯达克股票代码:AAPL)的股票历来表现疲软,但今年带来了希望,假日预期很高,供应条件也比去年有所改善。
In "Johnson & Johnson Stock Gains a Bull Ahead of Analyst Day," Emily Dattilo writes that UBS analysts upgraded Johnson & Johnson (NYSE:JNJ) to "Buy," citing a positive outlook for its Innovative Medicine business and MedTech growth in line with the market.
艾米丽·达蒂洛在 “分析师日前强生股票上涨” 中写道,瑞银分析师将强生(纽约证券交易所代码:JNJ)上调至 “买入”,理由是其创新医学业务前景乐观,医疗科技增长与市场一致。
Read Next: From Bearish To Bullish: Major Analysts Predict US Stock Market's Performance In 2024
继续阅读:从看跌到看涨:主要分析师预测美国股市在2024年的表现
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
该内容部分是在人工智能工具的帮助下制作的,并由Benzinga编辑审查和发布。
Photo: Shutterstock
照片:Shutterstock